By staff writers

September 5, 2013 -- Siemens Healthcare has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Symbia Intevo SPECT/CT system.

Intevo, the first member of Siemens' xSPECT product family, integrates data from both SPECT and CT modalities and generates high-resolution as well as quantitative SPECT images, according to the vendor.

Siemens has also included its CARE Dose4D technique, which can reduce patient CT radiation dose by up to 68%, while the system's Autoform collimator captures up to 26% more photon counts from radiotracer activity, according to the vendor.

Siemens first unveiled Intevo at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in June.

If you like this content, please share it with a colleague!
Copyright © 2013

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Sign in using your social networking account:
Sign in using your social networking